View in EDS HTML Full Text PDF Full Text

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.

Saved in:
Bibliographic Details
Title: Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.
Authors: Chan KH; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA.; Department of Internal Medicine, Division of Hematology/Oncology, Charleston Area Medical Center Cancer Center, USA., Cen P; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA., Shu T; Department of Urology, The University of Texas Health Science Center at Houston, USA., Canfield S; Department of Urology, The University of Texas Health Science Center at Houston, USA., Zhao H; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, USA., Gonzalez A; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA., Rowe J; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA., Tammisetti V; Department of Urology, The University of Texas Health Science Center at Houston, USA., Ayoub H; Department of Urology, The University of Texas Health Science Center at Houston, USA., Blanco A; Department of Neurosurgery, The University of Texas Health Science Center at Houston, USA., Amsbaugh M; Department of Neurosurgery, The University of Texas Health Science Center at Houston, USA., Tannir N; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, USA.
Source: The Journal of international medical research [J Int Med Res] 2026 Mar; Vol. 54 (3), pp. 3000605261430450. Date of Electronic Publication: 2026 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41885091
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+KH%22">Chan KH</searchLink>; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA.; Department of Internal Medicine, Division of Hematology/Oncology, Charleston Area Medical Center Cancer Center, USA.<br /><searchLink fieldCode="AU" term="%22Cen+P%22">Cen P</searchLink>; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Shu+T%22">Shu T</searchLink>; Department of Urology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Canfield+S%22">Canfield S</searchLink>; Department of Urology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez+A%22">Gonzalez A</searchLink>; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Rowe+J%22">Rowe J</searchLink>; Division of Hematology/Oncology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Tammisetti+V%22">Tammisetti V</searchLink>; Department of Urology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ayoub+H%22">Ayoub H</searchLink>; Department of Urology, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Blanco+A%22">Blanco A</searchLink>; Department of Neurosurgery, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Amsbaugh+M%22">Amsbaugh M</searchLink>; Department of Neurosurgery, The University of Texas Health Science Center at Houston, USA.<br /><searchLink fieldCode="AU" term="%22Tannir+N%22">Tannir N</searchLink>; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220346411%22">The Journal of international medical research</searchLink> [J Int Med Res] 2026 Mar; Vol. 54 (3), pp. 3000605261430450. <i>Date of Electronic Publication: </i>2026 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0346411 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-2300 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203000605%22">03000605 </searchLink><i>NLM ISO Abbreviation: </i>J Int Med Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41885091
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/03000605261430450
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3000605261430450
    Titles:
      – TitleFull: Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan KH
      – PersonEntity:
          Name:
            NameFull: Cen P
      – PersonEntity:
          Name:
            NameFull: Shu T
      – PersonEntity:
          Name:
            NameFull: Canfield S
      – PersonEntity:
          Name:
            NameFull: Zhao H
      – PersonEntity:
          Name:
            NameFull: Gonzalez A
      – PersonEntity:
          Name:
            NameFull: Rowe J
      – PersonEntity:
          Name:
            NameFull: Tammisetti V
      – PersonEntity:
          Name:
            NameFull: Ayoub H
      – PersonEntity:
          Name:
            NameFull: Blanco A
      – PersonEntity:
          Name:
            NameFull: Amsbaugh M
      – PersonEntity:
          Name:
            NameFull: Tannir N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1473-2300
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of international medical research
              Type: main
ResultId 1